36 results on '"Hutarew, Georg"'
Search Results
2. Correction to: HER2 copy number determination in breast cancer using the highly sensitive droplet digital PCR method
Catalog
Books, media, physical & digital resources
3. Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma
4. Genome-Wide Methylation Analysis in Two Wild-Type Non-Small Cell Lung Cancer Subgroups with Negative and High PD-L1 Expression
5. Genome-Wide Methylation Analysis in Two Wild-Type Non-small Cell Lung Cancer Subgroups with Low and High PD-L1 Expression Levels
6. The 2020 update of the recommendations of the Austrian working group on lung pathology and oncology for the diagnostic workup of non-small cell lung cancer with focus on predictive biomarkers
7. HER2 copy number determination in breast cancer using the highly sensitive droplet digital PCR method.
8. Correction to: HER2 copy number determination in breast cancer using the highly sensitive droplet digital PCR method
9. Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study
10. Dissecting the Methylomes of EGFR-Amplified Glioblastoma Reveals Altered DNA Replication and Packaging, and Chromatin and Gene Silencing Pathways
11. Teleneuropathology
12. PD-L1 testing, fit for routine evaluation? From a pathologist’s point of view
13. Recommendations of the Austrian Working Group on Pulmonary Pathology and Oncology for predictive molecular and immunohistochemical testing in non-small cell lung cancer
14. Methylome Profiling of PD-L1-Expressing Glioblastomas Shows Enrichment of Post-Transcriptional and RNA-Associated Gene Regulation
15. EGFR Amplification Is a Phenomenon of IDH Wildtype and TERT Mutated High-Grade Glioma: An Integrated Analysis Using Fluorescence In Situ Hybridization and DNA Methylome Profiling
16. Recommendations of the Austrian Working Group on Lung Pathology and Oncology for predictive molecular and immunohistochemical testing in non-small cell lung cancer
17. Sentinel Lymph Node Biopsy is Precise After Primary Systemic Therapy in Stage II–III Breast Cancer Patients
18. Immunohistochemistry as a screening tool for ALK rearrangement in NSCLC: evaluation of five different ALK antibody clones and ALK FISH
19. Die Intraoperative Radiotherapie mittels Elektronen (IOERT) als Boost-Strategie in der BET des Mammakarzinomes: Das Salzburger Konzept: V48
20. Evaluation of transition zone and lateral sextant biopsies for prostate cancer detection after initial sextant biopsy
21. Prostate cancer detection with two sets of ten-core compared with two sets of sextant biopsies
22. Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer
23. First line crizotinib in anaplastic lymphoma kinase (ALK) rearranged squamous cell lung cancer
24. CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer
25. ROS1 mutation and treatment with crizotinib in a 30-year old Caucasian woman with stage IV non-small cell lung cancer/adenocarcinoma and complete remission
26. Immunohistochemistry as a screening tool forALKrearrangement in NSCLC: evaluation of five different ALK antibody clones andALKFISH
27. PP142
28. Successful antiangiogenic combination therapy for pseudomyxoma peritonei with bevacizumab and capecitabine
29. Methylated NEUROD1 Promoter is a Marker for Chemosensitivity in Breast Cancer
30. Giant Pulmonary Hamartoma—A Rare Presentation of a Common Tumor
31. Comparison of an auto-stereoscopic display and polarized stereoscopic projection for macroscopic pathology
32. Two-year evaluation of telepathology
33. Prostate biopsy outcome using 33 MM cutting length
34. A rare manifestation of sarcoidosis with sensomotoric neuropathy of the ulnar nerve as the only symptom.
35. Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade.
36. PP142: Recurrent oral squamous cell carcinoma after resection and mandibular implant rehabilitation: A preliminary report of eight patients.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.